| Term: | prostaglandin E2 |
|
| Accession: | CHEBI:15551
|
 browse the term
 view annotations
|
| Definition: | Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins. |
| Synonyms: | exact_synonym: | (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid |
| | related_synonym: | (15S)-prostaglandin E2; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate; (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid; (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid; C20H32O5; CCCCC[C@H](O)\\C=C\\[C@H]1[C@H](O)CC(=O)[C@@H]1C\\C=C/CCCC(O)=O; Dinoproston; Dinoprostone; InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1; InChIKey=XEYBRNLFEZDVAW-ARSRFYASSA-N; PGE2; Prepidil; Propess; Prostin E2; dinoprostona; dinoprostonum |
| | alt_id: | CHEBI:10910; CHEBI:10911; CHEBI:114125; CHEBI:26323; CHEBI:4625; CHEBI:8512 |
| | xref_casrn: | 363-24-6 |
| | xref: | Beilstein:2224724 "Beilstein Registry Number"; ChEMBL:114125 "ChEMBL COMPOUND"; ChemIDplus:363-24-6 "CAS Registry Number"; DrugBank:DB00917 "DrugBank"; KEGG COMPOUND:363-24-6 "CAS Registry Number"; KEGG COMPOUND:C00584 "KEGG COMPOUND"; KEGG DRUG:D00079 "KEGG DRUG"; LIPID MAPS:LMFA03010003 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D015232 |
| | xref: | Patent:DE2011969 "Patent"; Patent:GB851827 "Patent"; Patent:NL6505799 "Patent"; Patent:US3598858 "Patent"; Wikipedia:Dinoprostone "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:606564 |
|
|
